ELUTIA INC. (ELUT)
Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women’s Health and Cardiovascular. Its lead development programs include NXT-41 and NXT-41x, which are designed as biologic scaffolds combined with local antibiotic delivery. The company provides SimpliDerm, a human acellular dermal matrix used in soft tissue reconstruction. It also offers ProxiCor for cardiac tissue repair for use as an intracardiac patch for repairs, such as atrial and ventricular septal defects and suture-line buttressing, and pledgets, as well as for pericardial closure to reconstruct the pericardium after heart surgery. In addition, the company provides Tyke, a thinner pliable matrix for the repair of pericardial structures for neonates and infants; as an epicardial for damaged or repaired cardiac structures; and as a patch material for cardiac defects, as well as VasCure, a patch material to repair or reconstruct the peripheral vasculature. The company sells its products directly to hospitals and other healthcare facilities through independent sales agents. The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023. Elutia Inc. was incorporated in 2015 and is headquartered in Gaithersburg, Maryland.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
Elutia Inc
NASDAQ:ELUTHealthcare · Biotechnology
+2.89%$0.8371
AH$0.8371+0.00%vs close
Mkt Cap$37.07M
Float38.06M
O/S44.29M
Vol
$ Vol
RVOL
Inst Own32.6%
SI<0.1%
Earnings
Dilution
Financials Summary
Revenue$12.29M
Net Income$53.38M
Total Assets$62.35M
Free Cash Flow-$46.69M
Debt & Equity
Debt 29%
Equity 71%
Total Debt$11.17M
Total Equity$27.67M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in ELUT's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$62.35M
Liabilities$34.68M
Accounts Receivable$14.58M
Accounts Payable$4.79M
Inventory$2.62M
PP&E (Net)$5M
Goodwill$0
Intangible Assets$1.53M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Revenue | $12.29M | $24.38M | $24.75M | $23.85M | $47.39M | $42.68M | $42.9M | $39.04M |
| YoY Growth | -49.6% | -1.5% | 3.8% | -49.7% | 11.0% | -0.5% | 9.9% | - |
| Cost of Revenue | $5.7M | $13.67M | $13.69M | $12.21M | $28.37M | $22.12M | $23.13M | $23.09M |
| Gross Profit | $6.6M | $10.71M | $11.05M | $11.64M | $19.02M | $20.56M | $19.77M | $15.95M |
| Gross Margin | 53.7% | 43.9% | 44.7% | 48.8% | 40.1% | 48.2% | 46.1% | 40.8% |
| Research and Development | $4.16M | $3.79M | $4.4M | $7.73M | $9.27M | $5.95M | $2.4M | $2.48M |
| Selling, General, and Administrative | $20.84M | $31.2M | $27.19M | $33.9M | $32.51M | $28.21M | $25.78M | $21.68M |
| Other | $0 | $11.37M | $9.99M | $5.2M | $276K | $0 | $0 | $0 |
| Total Operating Expenses | $25.01M | $46.36M | $41.58M | $46.83M | $42.05M | $34.16M | $28.18M | $24.17M |
| Operating Income (EBIT) | -$18.41M | -$35.65M | -$30.53M | -$35.19M | -$23.03M | -$13.6M | -$8.41M | -$8.22M |
| Operating Margin | -149.8% | -146.3% | -123.4% | -147.5% | -48.6% | -31.9% | -19.6% | -21.1% |
| Interest Expense | -$387K | $4.78M | $5.8M | $5.12M | $5.32M | $5.63M | $5.38M | $5.52M |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | $2.55M | -$18.47M | -$10.7M | -$959K | -$1.75M | -$8.2M | -$3.5M | -$3.32M |
| Income Before Tax (EBT) | -$15.86M | -$54.12M | -$41.22M | -$36.15M | -$24.78M | -$21.8M | -$11.91M | -$11.54M |
| Income Tax Expense | $13K | $7K | $28K | $34K | $55K | $26K | $30K | $26K |
| Net Income | $53.38M | -$53.95M | -$37.66M | -$32.9M | -$24.83M | -$21.82M | -$11.94M | -$11.57M |
| Net Income Margin | 434.2% | -221.3% | -152.2% | -137.9% | -52.4% | -51.1% | -27.8% | -29.6% |
| Supplementary Data | ||||||||
| EPS | 1.29 | -1.86 | -2.07 | -2.38 | -2.38 | -2.13 | -1.12 | -1.08 |
| Diluted EPS | 0.87 | -1.86 | -2.07 | -2.38 | -2.38 | -2.13 | -1.12 | -1.08 |
| Weighted Average OS | 41.42M | 29.07M | 18.16M | 13.83M | 10.44M | 10.23M | 10.67M | 10.67M |
| EBITDA | -$13.46M | -$48.26M | -$31.68M | -$27.3M | -$15.72M | -$12.3M | -$2.67M | -$2.22M |
| EBITDA Margin | -109.5% | -198.0% | -128.0% | -114.5% | -33.2% | -28.8% | -6.2% | -5.7% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and Cash Equivalents | $36.35M | $13.24M | $19.28M | $16.99M | $30.39M | $39.15M | $2.48M | $2.41M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $36.35M | $13.24M | $19.28M | $16.99M | $30.39M | $39.15M | $2.48M | $2.41M |
| Accounts Receivable | $14.58M | $7.04M | $5.96M | $17.59M | $6M | $7.17M | $7.23M | $7.2M |
| Inventory | $2.62M | $1.93M | $3.85M | $4.24M | $9.55M | $10.12M | $7.19M | $7.46M |
| Other Current Assets | $2.27M | $3.97M | $2.17M | $11.88M | $35K | $382K | $108K | $46K |
| Total Current Assets | $55.82M | $26.17M | $31.25M | $50.7M | $47.43M | $59.71M | $18.45M | $18.14M |
| Long-Term Assets | ||||||||
| Property, Plant & Equipment Net | $5M | $850K | $504K | $565K | $1.2M | $1.16M | $988K | $870K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $1.53M | $2.6M | $11.67M | $15.07M | $18.47M | $21.86M | $25.26M | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $6.5M | $0 | $2.51M | $76K | $76K | $76K | $28.74M |
| Total Long-Term Assets | $6.53M | $9.96M | $12.18M | $18.14M | $19.74M | $23.1M | $26.33M | $29.61M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $62.35M | $36.13M | $43.43M | $68.84M | $67.17M | $82.81M | $44.77M | $47.74M |
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts Payable | $4.79M | $4.15M | $3.19M | $1.37M | $1.58M | $2.05M | $2.49M | $1.59M |
| Short-Term Debt | $4.75M | $1.25M | $3.32M | $0 | $12.82M | $12.82M | $5.92M | $6.46M |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $5K | $533K | $650K | $0 |
| Other Current Liabilities | $11.24M | $25.15M | $26.77M | $31.28M | $2.75M | $2.75M | $2.75M | -$1.26M |
| Total Current Liabilities | $25.14M | $37.8M | $43.04M | $42.62M | $26M | $26.78M | $18.27M | $13.35M |
| Long-Term Liabilities | ||||||||
| Long-Term Debt | $2.83M | $22.6M | $20.36M | $24.26M | $10.41M | $17.81M | $19.61M | $75.92M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $698K | $756K | $705K | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $3.12M | $21.97M | $18.64M | $6.04M | $16.54M | $16.63M | $61.29M | $1.88M |
| Total Long-Term Liabilities | $9.54M | $44.59M | $38.99M | $31.26M | $27.65M | $35.2M | $81.61M | $77.8M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $34.68M | $82.39M | $82.03M | $73.87M | $53.65M | $61.98M | $99.88M | $91.15M |
| Stockholders' Equity | ||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $43K | $35K | $23K | $16K | $13K | $10K | $1K | $9K |
| Retained Earnings | -$176.21M | -$229.59M | -$175.64M | -$137.99M | -$105.09M | -$80.26M | -$56.94M | -$45M |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 | -$80.26M | -$56.94M | $0 |
| Other Stockholders' Equity | $203.84M | $183.3M | $137.02M | $132.94M | $118.6M | $101.08M | $1.83M | $1.58M |
| Total Equity | $27.67M | -$46.26M | -$38.6M | -$5.03M | $13.52M | $20.83M | -$55.11M | -$43.41M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $62.35M | $36.13M | $43.43M | $68.84M | $67.17M | $82.81M | $44.77M | $47.74M |
| Supplementary Data | ||||||||
| Total Debt | $11.17M | $24.01M | $23.95M | $25.45M | $23.24M | $30.64M | $25.53M | $82.39M |
| Net Debt | -$25.18M | $10.78M | $4.68M | $8.46M | -$7.16M | -$8.52M | $23.05M | $79.97M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Operating Activities | ||||||||
| Net Income | $53.38M | -$53.95M | -$37.66M | -$32.9M | -$24.83M | -$21.82M | -$11.94M | -$11.57M |
| Depreciation & Amortization | $2.79M | $1.08M | $3.75M | $3.73M | $3.73M | $3.86M | $3.86M | $3.8M |
| Deferred Income Tax | $13K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $4.4M | $7.89M | $2.44M | $3.65M | $3.54M | $779K | $208K | $0 |
| Changes in Working Capital: | ||||||||
| Accounts Receivable | -$2K | $527K | $802K | -$14.65M | $1.17M | $64K | -$30K | -$1.61M |
| Inventory | -$1.64M | -$58K | -$609K | -$498K | $563K | -$2.93M | $269K | $1.1M |
| Accounts Payable | -$6.55M | $0 | $0 | $0 | $0 | $0 | -$627K | $352K |
| Other Working Capital | -$10.54M | $3.62M | $8.88M | $20.86M | $642K | $196K | -$79K | $1.54M |
| Total Working Capital Change | -$18.73M | $4.09M | $9.07M | $5.71M | $2.38M | -$2.67M | -$467K | $1.38M |
| Other Non-Cash Items | -$86.65M | $18.23M | $638K | -$1.63M | -$254K | $6.22M | $1.12M | $9.02M |
| Net Cash from Operating | -$44.81M | -$22.66M | -$21.76M | -$21.43M | -$15.45M | -$13.63M | -$7.22M | -$5.13M |
| Investing Activities | ||||||||
| Capital Expenditures | -$1.88M | -$654K | -$346K | -$540K | -$369K | -$640K | -$577K | -$190K |
| Acquisitions | $80.44M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $180K | $14.55M | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | $78.56M | -$474K | $14.21M | -$540K | -$369K | -$640K | -$577K | -$190K |
| Financing Activities | ||||||||
| Debt Repaid | $23.06M | $2M | $1.96M | -$6.38M | $2.78M | -$4.7M | -$4.14M | $3.64M |
| Common Stock Issuance | $13.91M | $0 | $0 | $10.09M | $13.75M | $43.02M | $0 | $0 |
| Common Stock Repurchases | $0 | -$1.19M | -$32K | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$1.48M | $20.28M | $11.83M | -$3.18M | -$2.51M | -$2.24M | -$1.03M | $10.51M |
| Net Cash from Financing | -$10.64M | $17.09M | $9.84M | $8.54M | $6.71M | $51.21M | $7.98M | $6.99M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $23.11M | -$6.04M | $2.29M | -$13.44M | -$9.1M | $36.94M | $177K | $1.67M |
| Supplementary Data | ||||||||
| Operating Cash Flow | -$44.81M | -$22.66M | -$21.76M | -$21.43M | -$15.45M | -$13.63M | -$7.22M | -$5.13M |
| Capital Expenditure | -$1.88M | -$654K | -$346K | -$540K | -$369K | -$640K | -$577K | -$190K |
| Free Cash Flow | -$46.69M | -$23.31M | -$22.11M | -$21.97M | -$15.81M | -$14.27M | -$7.8M | -$5.32M |
| Cash at Beginning | $13.24M | $19.28M | $16.99M | $30.43M | $39.53M | $2.59M | $2.41M | $739K |
| Cash at End | $36.35M | $13.24M | $19.28M | $16.99M | $30.43M | $39.53M | $2.59M | $2.41M |